{"rows":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5679,"title":"Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.","authors":"Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I","journal":"Journal of neuroscience methods","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jneumeth.2026.110848","pubmed_id":"42401399","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Biomarkers,Aging,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-09 01:20:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42401399","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42401399","source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","doi":"10.1016/j.jneumeth.2026.110848","pmid":"42401399","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":302,"title":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","authors":"Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš","journal":"Pharmacology Biochemistry and Behavior","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.pbb.2026.174231","pubmed_id":"42379524","openalex_id":"https://openalex.org/W7166640155","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","substance_tags":"psilocin","topic_tags":"Neurogenesis,Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379524","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.pbb.2026.174231","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379524","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","doi":"10.1016/j.pbb.2026.174231","pmid":"42379524","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":120,"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","authors":"Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.","journal":"American Journal of Preventive Medicine","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.amepre.2026.108381","pubmed_id":"42092643","openalex_id":"https://openalex.org/W7160017394","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42092643","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.amepre.2026.108381","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42092643","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","doi":"10.1016/j.amepre.2026.108381","pmid":"42092643","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5783,"title":"Single-crystal structure determination of psilocybin after dehydration","authors":"Emmett Sonya K., Cameron Lee, Hestermann Mark, Holland Darren, Kessler Simon, McFarlane Luke, Chooi Yit-Heng, Moggach Stephen A.","journal":"Acta Crystallographica Section C Structural Chemistry","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1107/s2053229626007692","pubmed_id":"42566287","openalex_id":"https://openalex.org/W7201840591","source_url":"https://doi.org/10.1107/s2053229626007692","substance_tags":"psilocybin","topic_tags":"General","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-08 01:20:18","last_checked":"2026-08-14 01:20:15","bibtex":null,"source_record_id":"PMID:42566287","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1107/s2053229626007692","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42566287","source_url":"https://doi.org/10.1107/s2053229626007692","doi":"10.1107/s2053229626007692","pmid":"42566287","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4197,"title":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.","authors":"Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251381806","pubmed_id":"42539773","openalex_id":"https://openalex.org/W7117566828","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539773","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539773","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","doi":"10.1177/28314425251381806","pmid":"42539773","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4190,"title":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251387655","pubmed_id":"42539824","openalex_id":"https://openalex.org/W7117646156","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539824","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":301,"title":"Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress","authors":"Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki","journal":"Neuropsychopharmacology Reports","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/npr2.70152","pubmed_id":"42379141","openalex_id":"https://openalex.org/W7166665532","source_url":"https://doi.org/10.1002/npr2.70152","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379141","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/npr2.70152","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379141","source_url":"https://doi.org/10.1002/npr2.70152","doi":"10.1002/npr2.70152","pmid":"42379141","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":51,"title":"Balancing safety and access in Oregon’s psilocybin services","authors":"Cheung Katherine, Propes Caleigh, Yaden David B.","journal":"International Journal of Drug Policy","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105384","pubmed_id":"42288041","openalex_id":"https://openalex.org/W7164654902","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288041","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288041","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","doi":"10.1016/j.drugpo.2026.105384","pmid":"42288041","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":50,"title":"Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases","authors":"Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew","journal":"Metabolic Engineering","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.ymben.2026.102490","pubmed_id":"42288133","openalex_id":"https://openalex.org/W7164759173","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Genomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288133","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.ymben.2026.102490","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288133","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","doi":"10.1016/j.ymben.2026.102490","pmid":"42288133","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":46,"title":"Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.","authors":"Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC","journal":"Journal of clinical psychology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/jclp.70167","pubmed_id":"42296474","openalex_id":"https://openalex.org/W7164838909","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42296474","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42296474","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","doi":"10.1002/jclp.70167","pmid":"42296474","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5864,"title":"Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.","authors":"Kelly C, Cooley BJ, Zeng L, Hurzeler T, Manning V, McNally GP, Watt J, Haber PS, Morley KC.","journal":"Neuroscience and biobehavioral reviews","publication_date":"2026-08-14","publication_year":2026,"doi":"10.1016/j.neubiorev.2026.106911","pubmed_id":"42600962","openalex_id":null,"source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Systematic Review,Review Article,Animal Study,Safety","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-16 01:20:05","last_checked":"2026-08-17 01:20:26","bibtex":null,"source_record_id":"PMID:42600962","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42600962","source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","doi":"10.1016/j.neubiorev.2026.106911","pmid":"42600962","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3626,"title":"The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults","authors":"Region Skane","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07169747","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-17 01:21:44","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07169747","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07169747","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07169747","source_url":"https://clinicaltrials.gov/study/NCT07169747","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3602,"title":"Safety for Home Administration of Microdose Psilocybin Use","authors":"Johns Hopkins University","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06450210","substance_tags":"psilocybin","topic_tags":"Microdosing,Healthy Volunteers,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-17 01:21:44","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06450210","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06450210","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06450210","source_url":"https://clinicaltrials.gov/study/NCT06450210","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3525,"title":"Psilocybin Administration With 5-HT1a Blockade","authors":"Johns Hopkins University","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07565493","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Receptor Pharmacology,Consciousness,Observational Study,Healthy Volunteers","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-17 01:21:44","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07565493","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07565493","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07565493","source_url":"https://clinicaltrials.gov/study/NCT07565493","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3472,"title":"A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07226232","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-17 01:21:44","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07226232","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07226232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07226232","source_url":"https://clinicaltrials.gov/study/NCT07226232","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5863,"title":"Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy","authors":"Brian Ross","journal":"Journal of Psychedelic Studies","publication_date":"2026-08-13","publication_year":2026,"doi":"10.1556/2054.2026.00517","pubmed_id":null,"openalex_id":"https://openalex.org/W7202362192","source_url":"https://doi.org/10.1556/2054.2026.00517","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Animal Study,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-15 01:20:13","last_checked":"2026-08-17 01:20:29","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00517","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2026.00517","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00517","source_url":"https://doi.org/10.1556/2054.2026.00517","doi":"10.1556/2054.2026.00517","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}}],"total":4959,"page":1,"per_page":20,"pages":248,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}